Jefferies Sees Haemonetics (HAE) as Oversold Ahead of Earnings, PT Lowered $105

May 12, 2021 8:10 AM

Jefferies analyst Anthony Petrone lowered the price target on Haemonetics (NYSE: HAE) to $105.00 (from $185.00) ahead of the F4Q ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found